To identify and isolate HCC CSC populations, at least 12 different phenotypical CSC markers (e.g., CD133/Prominin-1, CD90/Thy-1, EpCAM/CD326, CD13, and ABCG2) have been used. This evidence concerns the gene EPCAM and hepatocellular carcinoma.